Results 201 to 210 of about 3,270,422 (387)
Synthesis, cloning, and identification of DNA sequences complementary to mRNAs for alpha and beta subunits of thyrotropin. [PDF]
, 1980 Nikos C. Vamvakopoulos +2 more
openalex +1 more source
Hydration scheme of the complementary base‐pairs of DNA [PDF]
FEBS Letters, 1978 Alberte Pullman +2 more
openaire +3 more sources
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren +16 more
wiley +1 more source
COMPLEMENTARY FRACTIONS OF DENATURED DNA OF COLIPHAGE T3 AS TEMPLATES FOR TRANSCRIPTION
, 1969 Loretta Cheong, Erwin Chargaff
openalex +1 more source
Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide. [PDF]
, 1988 Katsuya Yamamoto +6 more
openalex +1 more source
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Legal Claims toward SARS-CoV-2 Complementary DNA Integrated into the Human Genome
, 2021 Lisewski AM.
europepmc +1 more source
Isolation of chicken hemoglobin mRNA and synthesis of complementary DNA.
, 1977 Shirley Longacre, William J. Rutter
openalex +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source